
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $1B | -- | -- | $1.07 | -- |
07/30/2025 | Q2 | $1B | -- | -- | $1.05 | -- |
05/01/2025 | Q1 | $1B | $1B | -$0.08 | $1.02 | -$1.10 |
02/05/2025 | Q4 | $1B | $1B | $0.87 | $1.02 | -$0.15 |
11/04/2024 | Q3 | $976.7M | $988M | $0.76 | $1.01 | -$0.25 |
07/29/2024 | Q2 | $1B | $1B | $0.82 | $1.01 | -$0.19 |
05/02/2024 | Q1 | $1B | $1B | $0.72 | $0.98 | -$0.26 |
02/01/2024 | Q4 | $983.6M | $1B | $1.03 | $0.95 | $0.08 |
11/09/2023 | Q3 | $939.9M | $945.3M | $0.37 | $0.84 | -$0.47 |
07/31/2023 | Q2 | $963.3M | $984.4M | -$0.16 | $0.89 | -$1.05 |
05/01/2023 | Q1 | -- | $1B | $0.87 | -- | -- |
02/01/2023 | Q4 | -- | $1.1B | $0.75 | -- | -- |
10/31/2022 | Q3 | -- | $953.2M | $0.47 | -- | -- |
07/27/2022 | Q2 | -- | $1B | $0.90 | -- | -- |
04/27/2022 | Q1 | -- | $1.4B | $1.80 | -- | -- |
02/02/2022 | Q4 | -- | $1.5B | $1.95 | -- | -- |
11/01/2021 | Q3 | -- | $1.3B | $1.28 | -- | -- |
07/28/2021 | Q2 | -- | $1.2B | $1.04 | -- | -- |
04/28/2021 | Q1 | -- | $1.5B | $2.38 | -- | -- |
01/27/2021 | Q4 | -- | $1.6B | $2.50 | -- | -- |
11/04/2020 | Q3 | -- | $1.3B | $1.88 | -- | -- |
07/29/2020 | Q2 | -- | $822.9M | $0.53 | -- | -- |
04/29/2020 | Q1 | -- | $756.1M | $0.36 | -- | -- |
01/29/2020 | Q4 | -- | $850.5M | $1.43 | -- | -- |
11/06/2019 | Q3 | -- | $865.9M | $0.15 | -- | -- |
07/31/2019 | Q2 | -- | $852.4M | $0.35 | -- | -- |
05/01/2019 | Q1 | -- | $818.4M | -$1.01 | -- | -- |
01/30/2019 | Q4 | -- | $830.7M | $0.36 | -- | -- |
11/07/2018 | Q3 | -- | $813.4M | $0.18 | -- | -- |
07/31/2018 | Q2 | -- | $824M | $0.41 | -- | -- |
05/02/2018 | Q1 | -- | $789.3M | -$2.46 | -- | -- |
02/08/2018 | Q4 | -- | $791.1M | $1.45 | -- | -- |
11/08/2017 | Q3 | -- | $802.9M | $0.29 | -- | -- |
08/02/2017 | Q2 | -- | $806.1M | $0.21 | -- | -- |
05/10/2017 | Q1 | -- | $715.4M | $1.84 | -- | -- |
02/01/2017 | Q4 | -- | $734.4M | $0.30 | -- | -- |
11/02/2016 | Q3 | -- | $726.9M | $0.33 | -- | -- |
07/27/2016 | Q2 | -- | $717.4M | $0.30 | -- | -- |
04/27/2016 | Q1 | -- | $693.3M | $0.24 | -- | -- |
01/27/2016 | Q4 | -- | $695.2M | $0.29 | -- | -- |
11/04/2015 | Q3 | -- | $702.8M | $0.09 | -- | -- |
Hologic reported $1B worth of top line sales in its most recent quarter.
Hologic announced earnings per share of -$0.08 which represents a miss of analyst forecast a $1.02 per share.
Hologic reported $377.3M that represents $1.67 per share over the last quarter.
Hologic's earnings are forecast to grow from $3.32 per share to $4.08 per share next year representing an increase of 25.85%.
Hologic's next earnings date is July 30, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.